[
  {
    "ts": null,
    "headline": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=726bc25137e0f0af2f19dd8a400505c2047bbbf891c687f7ac1ce88665e56a68",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742922480,
      "headline": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
      "id": 133500039,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=726bc25137e0f0af2f19dd8a400505c2047bbbf891c687f7ac1ce88665e56a68"
    }
  },
  {
    "ts": null,
    "headline": "BIOGEN : TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS MAY 1, 2025",
    "summary": "Cambridge, Mass.- Biogen Inc. today announced it will report first quarter 2025 financial results Thursday, May 1, 2025, before the financial markets open. Following the release...",
    "url": "https://finnhub.io/api/news?id=8ded0e3df9197ecdaf7461d2186eb56d2b6cfd95546b4dc0a6c8dc27a8721f53",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742919254,
      "headline": "BIOGEN : TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS MAY 1, 2025",
      "id": 133403610,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "Cambridge, Mass.- Biogen Inc. today announced it will report first quarter 2025 financial results Thursday, May 1, 2025, before the financial markets open. Following the release...",
      "url": "https://finnhub.io/api/news?id=8ded0e3df9197ecdaf7461d2186eb56d2b6cfd95546b4dc0a6c8dc27a8721f53"
    }
  },
  {
    "ts": null,
    "headline": "Cassava Sciences shuts down Alzheimer's program - shares plummet",
    "summary": "Cassava Science's shares fell more than 20 percent in early trading in the United States on the news that the company is discontinuing its program to develop a drug for Alzheimer's. The program will...",
    "url": "https://finnhub.io/api/news?id=0ba6bc731967918d617c6fbd96d86d07e9edc0bb59a44fbbe7f4d86d027f250e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742895488,
      "headline": "Cassava Sciences shuts down Alzheimer's program - shares plummet",
      "id": 133375018,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "Cassava Science's shares fell more than 20 percent in early trading in the United States on the news that the company is discontinuing its program to develop a drug for Alzheimer's. The program will...",
      "url": "https://finnhub.io/api/news?id=0ba6bc731967918d617c6fbd96d86d07e9edc0bb59a44fbbe7f4d86d027f250e"
    }
  }
]